Access the full text.
Sign up today, get DeepDyve free for 14 days.
Our lead article this month covers a study by Lähteenvuo et al. that addresses a topic that should be of interest to all of our readers: what is the real‐world effectiveness of different drug treatments for bipolar disorder? This paper would be important at any time, but its appearance at this moment seems particularly fortuitous, in light of a recent opinion piece by Post in the Journal of the American Medical Association, one of the most influential journals in medicine. In his piece, Post draws an analogy to cancer in formulating his plea for a more aggressive approach to the management of bipolar disorder in order to prevent its “malignant transformation.”
The Brown University Psychopharmacology Update – Wiley
Published: Jan 1, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.